Company Filing History:
2 out of 6,602 
2 out of 16,338 
2 out of 59 Years Active: 2005-2012
Title: Kristen Briggs: Innovator in Plant Biotechnology
Introduction
Kristen Briggs is a prominent inventor based in Del Mar, California, known for her significant contributions to the field of plant biotechnology. With a total of six patents to her name, she has made remarkable advancements in the production of immunoglobulins and the treatment of metabolic disorders.
Latest Patents
One of her latest patents is titled "Plant production of immunoglobulins with reduced fucosylation." This invention provides for the plant production of immunoglobulins, wherein at least a portion of the glycans attached to the immunoglobulins lack fucose. The invention also includes constructs, plasmids, vectors, transformed plant cells, transformed plant calli, transformed plant tissues (e.g., leaves, seeds, tubers, etc.), transformed whole plants used to produce such immunoglobulins, methods of producing the immunoglobulins, the immunoglobulins produced by the disclosed methods, and the use of such immunoglobulins. Another significant patent is "Agonists and antagonists of prolixin for the treatment of metabolic disorders." This invention relates to the field of metabolic research, particularly the discovery of compounds effective for reducing body mass and useful for treating obesity-related diseases and disorders. The obesity-related diseases or disorders envisioned to be treated by the methods of the invention include, but are not limited to, hyperlipidemia, atherosclerosis, insulin resistance, diabetes, and hypertension. The invention provides methods of identifying and using agonists and antagonists of prolixin activity, wherein said activity is selected from the group consisting of lipid partitioning, lipid metabolism, and insulin-like activity.
Career Highlights
Throughout her career, Kristen has worked with notable companies such as Pioneer Hi-Bred International, Inc. and E.I. DuPont de Nemours and Company. Her work in these organizations has allowed her to develop and refine her innovative ideas in plant biotechnology.
Collaborations
Kristen has collaborated with esteemed colleagues, including John Mark Lucas and Kanwarpal Singh Dhugga, to further her research and development efforts in her field.
Conclusion
Kristen Briggs is a trailblazer in the realm of plant biotechnology, with her innovative patents paving the way for advancements in immunoglobulin production and metabolic disorder treatments. Her contributions continue to impact the scientific community and improve health outcomes